Xin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xin Li has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Jinku Bao
Sichuan University
3 shared publications - Ling Ye
Department of Pain Management, West China Hospital, Sichuan University, Chengdu, China
3 shared publications Chuanfang Wu
College of Life Sciences and Key Laboratory of Bio‐resources and Eco‐environment Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University Chengdu China
2 shared publications- Heng Tu
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, CHINA
2 shared publications - Jianzong Li
Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, Sichuan, P. R. China
2 shared publications - Jing Yang
State Key Laboratory of Oral Diseases National Center for Stomatology National Clinical Research Center for Oral Diseases Department of Cariology and Endodontics West China Hospital of Stomatology Sichuan University Chengdu Sichuan China
2 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e63453
Dental Undergraduate Students’ Perceptions of Blended Learning in the COVID-19 and Post–COVID-19 Years: Survey Study
Background: The outbreak of the COVID-19 pandemic created significant challenges but also a unique opportunity, accelerating the evolution of higher education, including dental education. This encouraged dental education to adopt more flexible modes like blended learning. Objective: This study aimed to explore senior undergraduate dental students’ views on blended learning during and after the COVID-19 pandemic and to identify modifiable factors influencing their engagement. Methods: A survey was conducted among final-year undergraduate students at a top-ranking dental school in mainland China during the fall semesters of 2020-2021 and 2023-2024. The survey assessed satisfaction with blended learning, preferences for engagement, strengths compared to purely online or offline teaching, and factors influencing engagement during and after the pandemic. Results: Response rates were 75% (85/114) in 2020 and 73% (47/64) in 2023. Blended learning was used in 53% (26/49) of evaluated courses. High satisfaction was reported by 82% (93/114) in 2020 and 59% (38/64) in 2023, with significant differences between high- and low-satisfaction groups (P<.001). Satisfaction with specific course types and learning activities was analyzed. Factors associated with higher satisfaction were evaluated using Pearson correlation. Students acknowledged the strengths of blended learning over online- or offline-only formats. In total, 70% (80/114) in 2020 and 61% (39/64) in 2023 expressed a desire to participate in blended dental education. Factors decreasing engagement included unstable technical support (68/114, 60% in 2020 vs 26/64, 41% in 2023), poor online-offline integration (58/114, 51% vs 34/64, 53%), lack of motivation (51/114, 45% vs 24/64, 38%), and insufficient teacher-student interaction (44/114, 39% vs 20/64, 31%). Factors increasing engagement included high-quality learning materials (76/114, 67% vs 43/64, 67%) and improved technical environments (62/114, 54% vs 35/64, 55%). Conclusions: Final-year dental students were generally satisfied with blended learning and recognized its strengths compared to purely online or offline formats, both during and after the pandemic. More efforts are required to enhance students’ potential engagement in blended learning for the future.
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e63453
Open AccessDental Undergraduate Students’ Perceptions of Blended Learning in the COVID-19 and Post–COVID-19 Years: Survey Study
Background: The outbreak of the COVID-19 pandemic created significant challenges but also a unique opportunity, accelerating the evolution of higher education, including dental education. This encouraged dental education to adopt more flexible modes like blended learning. Objective: This study aimed to explore senior undergraduate dental students’ views on blended learning during and after the COVID-19 pandemic and to identify modifiable factors influencing their engagement. Methods: A survey was conducted among final-year undergraduate students at a top-ranking dental school in mainland China during the fall semesters of 2020-2021 and 2023-2024. The survey assessed satisfaction with blended learning, preferences for engagement, strengths compared to purely online or offline teaching, and factors influencing engagement during and after the pandemic. Results: Response rates were 75% (85/114) in 2020 and 73% (47/64) in 2023. Blended learning was used in 53% (26/49) of evaluated courses. High satisfaction was reported by 82% (93/114) in 2020 and 59% (38/64) in 2023, with significant differences between high- and low-satisfaction groups (P<.001). Satisfaction with specific course types and learning activities was analyzed. Factors associated with higher satisfaction were evaluated using Pearson correlation. Students acknowledged the strengths of blended learning over online- or offline-only formats. In total, 70% (80/114) in 2020 and 61% (39/64) in 2023 expressed a desire to participate in blended dental education. Factors decreasing engagement included unstable technical support (68/114, 60% in 2020 vs 26/64, 41% in 2023), poor online-offline integration (58/114, 51% vs 34/64, 53%), lack of motivation (51/114, 45% vs 24/64, 38%), and insufficient teacher-student interaction (44/114, 39% vs 20/64, 31%). Factors increasing engagement included high-quality learning materials (76/114, 67% vs 43/64, 67%) and improved technical environments (62/114, 54% vs 35/64, 55%). Conclusions: Final-year dental students were generally satisfied with blended learning and recognized its strengths compared to purely online or offline formats, both during and after the pandemic. More efforts are required to enhance students’ potential engagement in blended learning for the future.
- Open Access
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Dental Undergraduate Students’ Perceptions of Blended Learning in the COVID-19 and Post–COVID-19 Years: Survey Study (Preprint)
BACKGROUND The outbreak of the COVID-19 pandemic created significant challenges but also a unique opportunity, accelerating the evolution of higher education, including dental education. This encouraged dental education to adopt more flexible modes like blended learning. OBJECTIVE This study aimed to explore senior undergraduate dental students’ views on blended learning during and after the COVID-19 pandemic and to identify modifiable factors influencing their engagement. METHODS A survey was conducted among final-year undergraduate students at a top-ranking dental school in mainland China during the fall semesters of 2020-2021 and 2023-2024. The survey assessed satisfaction with blended learning, preferences for engagement, strengths compared to purely online or offline teaching, and factors influencing engagement during and after the pandemic. RESULTS Response rates were 75% (85/114) in 2020 and 73% (47/64) in 2023. Blended learning was used in 53% (26/49) of evaluated courses. High satisfaction was reported by 82% (93/114) in 2020 and 59% (38/64) in 2023, with significant differences between high- and low-satisfaction groups (P<.001). Satisfaction with specific course types and learning activities was analyzed. Factors associated with higher satisfaction were evaluated using Pearson correlation. Students acknowledged the strengths of blended learning over online- or offline-only formats. In total, 70% (80/114) in 2020 and 61% (39/64) in 2023 expressed a desire to participate in blended dental education. Factors decreasing engagement included unstable technical support (68/114, 60% in 2020 vs 26/64, 41% in 2023), poor online-offline integration (58/114, 51% vs 34/64, 53%), lack of motivation (51/114, 45% vs 24/64, 38%), and insufficient teacher-student interaction (44/114, 39% vs 20/64, 31%). Factors increasing engagement included high-quality learning materials (76/114, 67% vs 43/64, 67%) and improved technical environments (62/114, 54% vs 35/64, 55%). CONCLUSIONS Final-year dental students were generally satisfied with blended learning and recognized its strengths compared to purely online or offline formats, both during and after the pandemic. More efforts are required to enhance students’ potential engagement in blended learning for the future.
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDental Undergraduate Students’ Perceptions of Blended Learning in the COVID-19 and Post–COVID-19 Years: Survey Study (Preprint)
BACKGROUND The outbreak of the COVID-19 pandemic created significant challenges but also a unique opportunity, accelerating the evolution of higher education, including dental education. This encouraged dental education to adopt more flexible modes like blended learning. OBJECTIVE This study aimed to explore senior undergraduate dental students’ views on blended learning during and after the COVID-19 pandemic and to identify modifiable factors influencing their engagement. METHODS A survey was conducted among final-year undergraduate students at a top-ranking dental school in mainland China during the fall semesters of 2020-2021 and 2023-2024. The survey assessed satisfaction with blended learning, preferences for engagement, strengths compared to purely online or offline teaching, and factors influencing engagement during and after the pandemic. RESULTS Response rates were 75% (85/114) in 2020 and 73% (47/64) in 2023. Blended learning was used in 53% (26/49) of evaluated courses. High satisfaction was reported by 82% (93/114) in 2020 and 59% (38/64) in 2023, with significant differences between high- and low-satisfaction groups (P<.001). Satisfaction with specific course types and learning activities was analyzed. Factors associated with higher satisfaction were evaluated using Pearson correlation. Students acknowledged the strengths of blended learning over online- or offline-only formats. In total, 70% (80/114) in 2020 and 61% (39/64) in 2023 expressed a desire to participate in blended dental education. Factors decreasing engagement included unstable technical support (68/114, 60% in 2020 vs 26/64, 41% in 2023), poor online-offline integration (58/114, 51% vs 34/64, 53%), lack of motivation (51/114, 45% vs 24/64, 38%), and insufficient teacher-student interaction (44/114, 39% vs 20/64, 31%). Factors increasing engagement included high-quality learning materials (76/114, 67% vs 43/64, 67%) and improved technical environments (62/114, 54% vs 35/64, 55%). CONCLUSIONS Final-year dental students were generally satisfied with blended learning and recognized its strengths compared to purely online or offline formats, both during and after the pandemic. More efforts are required to enhance students’ potential engagement in blended learning for the future.
- 11 November 2023
- Published by Elsevier in Biochemical Pharmacology
- Vol. 218, 115922
Effects of propranolol on glucose metabolism in hemangioma-derived endothelial cells
- 11 November 2023
- Published by Elsevier in Biochemical Pharmacology
- Vol. 218, 115922
Effects of propranolol on glucose metabolism in hemangioma-derived endothelial cells
- Open Access
- 26 April 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 881396
The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
Inflammation has emerged as a key player in regulating cancer initiation, progression, and therapeutics, acting as a double edged sword either facilitating cancer progression and therapeutic resistance or inducing anti-tumor immune responses. Accumulating evidence has linked the epigenetic modifications of histones to inflammation and cancer, and histone modifications-based strategies have shown promising therapeutic potentials against cancer. The jumonji C domain-containing (JMJD) family histone demethylases have exhibited multiple regulator functions in inflammatory processes and cancer development, and a number of therapeutic strategies targeting JMJD histone demethylases to modulate inflammatory cells and their products have been successfully evaluated in clinical or preclinical tumor models. This review summarizes current understanding of the functional roles and mechanisms of JMJD histone demethylases in crosstalk between inflammation and cancer, and highlights recent clinical and preclinical progress on harnessing the JMJD histone demethylases to regulate cancer-related inflammation for future cancer therapeutics.
- 26 April 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 881396
Open AccessThe JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
Inflammation has emerged as a key player in regulating cancer initiation, progression, and therapeutics, acting as a double edged sword either facilitating cancer progression and therapeutic resistance or inducing anti-tumor immune responses. Accumulating evidence has linked the epigenetic modifications of histones to inflammation and cancer, and histone modifications-based strategies have shown promising therapeutic potentials against cancer. The jumonji C domain-containing (JMJD) family histone demethylases have exhibited multiple regulator functions in inflammatory processes and cancer development, and a number of therapeutic strategies targeting JMJD histone demethylases to modulate inflammatory cells and their products have been successfully evaluated in clinical or preclinical tumor models. This review summarizes current understanding of the functional roles and mechanisms of JMJD histone demethylases in crosstalk between inflammation and cancer, and highlights recent clinical and preclinical progress on harnessing the JMJD histone demethylases to regulate cancer-related inflammation for future cancer therapeutics.
- 25 November 2021
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 100 (3) , 373-384
Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy
Osteolytic bone destruction is found in approximately 60% of advanced breast cancer patients. With the pathogenesis of bone metastasis being unclear, traditional antiresorptive therapeutic strategies might not be ideal for treatment. The Wnt pathway is a highly organized cascade involved in multiple stages of cancer bone metastasis, and Wnt-targeted therapeutic strategies have shown promise in achieving favorable outcomes. In this review, we summarize the current progress of pharmacological Wnt modulators against breast cancer bone metastasis, discuss emerging therapeutic strategies based on Wnt pathway-related targets for bone therapy, and highlight opportunities to better harness the Wnt pathway for bone metastasis therapeutics to further reveal the implications of the Wnt pathway in bone metastasis pathology and provide new ideas for the development of Wnt-based intervention strategies against breast cancer bone metastasis.
- 25 November 2021
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 100 (3) , 373-384
Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy
Osteolytic bone destruction is found in approximately 60% of advanced breast cancer patients. With the pathogenesis of bone metastasis being unclear, traditional antiresorptive therapeutic strategies might not be ideal for treatment. The Wnt pathway is a highly organized cascade involved in multiple stages of cancer bone metastasis, and Wnt-targeted therapeutic strategies have shown promise in achieving favorable outcomes. In this review, we summarize the current progress of pharmacological Wnt modulators against breast cancer bone metastasis, discuss emerging therapeutic strategies based on Wnt pathway-related targets for bone therapy, and highlight opportunities to better harness the Wnt pathway for bone metastasis therapeutics to further reveal the implications of the Wnt pathway in bone metastasis pathology and provide new ideas for the development of Wnt-based intervention strategies against breast cancer bone metastasis.
- Open Access
- 4 December 2019
- Published by Wiley in Cell Proliferation
- Vol. 53 (2) , e12735
Therapeutic potentials and modulatory mechanisms of fatty acids in bone
Bone metabolism is a lifelong process that includes bone formation and resorption. Osteoblasts and osteoclasts are the predominant cell types associated with bone metabolism, which is facilitated by other cells such as bone marrow mesenchymal stem cells (BMMSCs), osteocytes and chondrocytes. As an important component in our daily diet, fatty acids are mainly categorized as long‐chain fatty acids including polyunsaturated fatty acids (LCPUFAs), monounsaturated fatty acids (LCMUFAs), saturated fatty acids (LCSFAs), medium‐/short‐chain fatty acids (MCFAs/SCFAs) as well as their metabolites. Fatty acids are closely associated with bone metabolism and associated bone disorders. In this review, we summarized the important roles and potential therapeutic implications of fatty acids in multiple bone disorders, reviewed the diverse range of critical effects displayed by fatty acids on bone metabolism, and elucidated their modulatory roles and mechanisms on specific bone cell types. The evidence supporting close implications of fatty acids in bone metabolism and disorders suggests fatty acids as potential therapeutic and nutritional agents for the treatment and prevention of metabolic bone diseases.
- 4 December 2019
- Published by Wiley in Cell Proliferation
- Vol. 53 (2) , e12735
Open AccessTherapeutic potentials and modulatory mechanisms of fatty acids in bone
Bone metabolism is a lifelong process that includes bone formation and resorption. Osteoblasts and osteoclasts are the predominant cell types associated with bone metabolism, which is facilitated by other cells such as bone marrow mesenchymal stem cells (BMMSCs), osteocytes and chondrocytes. As an important component in our daily diet, fatty acids are mainly categorized as long‐chain fatty acids including polyunsaturated fatty acids (LCPUFAs), monounsaturated fatty acids (LCMUFAs), saturated fatty acids (LCSFAs), medium‐/short‐chain fatty acids (MCFAs/SCFAs) as well as their metabolites. Fatty acids are closely associated with bone metabolism and associated bone disorders. In this review, we summarized the important roles and potential therapeutic implications of fatty acids in multiple bone disorders, reviewed the diverse range of critical effects displayed by fatty acids on bone metabolism, and elucidated their modulatory roles and mechanisms on specific bone cell types. The evidence supporting close implications of fatty acids in bone metabolism and disorders suggests fatty acids as potential therapeutic and nutritional agents for the treatment and prevention of metabolic bone diseases.
- 21 August 2018
- Published by Wiley in Cell Proliferation
- Vol. 51 (6) , e12509
Computer‐aided identification of a novel pyruvate kinase M2 activator compound
Objectives: The aim of this study was to obtain antitumour molecules targeting to activate PKM 2 through adequate computational methods combined with biological activity experiments. Methods: The structure‐based virtual screening was utilized to screen effective activator targeting PKM 2 from ZINC database. Molecular dynamics simulations were performed to evaluate the stability of the small molecule‐binding PKM 2 complex systems. Then, cell survival experiments, glutaraldehyde crosslinking reaction, western blot, and qPCR experiments were used to detect the effects of top hits on various cancer cells and the targeting specificity of PKM 2. Results: Two small molecules in 1,5‐2H‐pyrrole‐dione were obtained after virtual screening. In vitro experiments demonstrated that ZINC 08383544 specifically activated PKM 2 and affected the expression of upstream and downstream genes of PKM 2 during glycolysis, leading to the inhibition of tumour cell growth. These results indicate that ZINC 08383544 conforms to the characteristics of PKM 2 activator and is potential to be a novel PKM 2 activator as antitumour drug. Discussion: This work proves that ZINC 08383544 promotes the formation of PKM 2 tetramer, effectively blocks PKM 2 nuclear translocation, and inhibits the growth of tumour, and ZINC 08383544 may be a novel activator of PKM 2. This work may provide a good choice of drug or molecular fragments for the antitumour strategy targeting PKM 2. Screening of targeted drugs by combination of virtual screening and bioactivity experiments is a rapid method for drug discovery.
- 21 August 2018
- Published by Wiley in Cell Proliferation
- Vol. 51 (6) , e12509
Computer‐aided identification of a novel pyruvate kinase M2 activator compound
Objectives: The aim of this study was to obtain antitumour molecules targeting to activate PKM 2 through adequate computational methods combined with biological activity experiments. Methods: The structure‐based virtual screening was utilized to screen effective activator targeting PKM 2 from ZINC database. Molecular dynamics simulations were performed to evaluate the stability of the small molecule‐binding PKM 2 complex systems. Then, cell survival experiments, glutaraldehyde crosslinking reaction, western blot, and qPCR experiments were used to detect the effects of top hits on various cancer cells and the targeting specificity of PKM 2. Results: Two small molecules in 1,5‐2H‐pyrrole‐dione were obtained after virtual screening. In vitro experiments demonstrated that ZINC 08383544 specifically activated PKM 2 and affected the expression of upstream and downstream genes of PKM 2 during glycolysis, leading to the inhibition of tumour cell growth. These results indicate that ZINC 08383544 conforms to the characteristics of PKM 2 activator and is potential to be a novel PKM 2 activator as antitumour drug. Discussion: This work proves that ZINC 08383544 promotes the formation of PKM 2 tetramer, effectively blocks PKM 2 nuclear translocation, and inhibits the growth of tumour, and ZINC 08383544 may be a novel activator of PKM 2. This work may provide a good choice of drug or molecular fragments for the antitumour strategy targeting PKM 2. Screening of targeted drugs by combination of virtual screening and bioactivity experiments is a rapid method for drug discovery.
- Open Access
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 10664
Structure and energy based quantitative missense variant effect analysis provides insights into drug resistance mechanisms of anaplastic lymphoma kinase mutations
Anaplastic lymphoma kinase (ALK) is considered as a validated molecular target in multiple malignancies, such as non-small cell lung cancer (NSCLC). However, the effectiveness of molecularly targeted therapies using ALK inhibitors is almost universally limited by drug resistance. Drug resistance to molecularly targeted therapies has now become a major obstacle to effective cancer treatment and personalized medicine. It is of particular importance to provide an improved understanding on the mechanisms of resistance of ALK inhibitors, thus rational new therapeutic strategies can be developed to combat resistance. We used state-of-the-art computational approaches to systematically explore the mutational effects of ALK mutations on drug resistance properties. We found the activation of ALK was increased by substitution with destabilizing mutations, creating the capacity to confer drug resistance to inhibitors. In addition, results implied that evolutionary constraints might affect the drug resistance properties. Moreover, an extensive profile of drugs against ALK mutations was constructed to give better understanding of the mechanism of drug resistance based on structural transitions and energetic variation. Our work hopes to provide an up-to-date mechanistic framework for understanding the mechanisms of drug resistance induced by ALK mutations, thus tailor treatment decisions after the emergence of resistance in ALK-dependent diseases.
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 10664
Open AccessStructure and energy based quantitative missense variant effect analysis provides insights into drug resistance mechanisms of anaplastic lymphoma kinase mutations
Anaplastic lymphoma kinase (ALK) is considered as a validated molecular target in multiple malignancies, such as non-small cell lung cancer (NSCLC). However, the effectiveness of molecularly targeted therapies using ALK inhibitors is almost universally limited by drug resistance. Drug resistance to molecularly targeted therapies has now become a major obstacle to effective cancer treatment and personalized medicine. It is of particular importance to provide an improved understanding on the mechanisms of resistance of ALK inhibitors, thus rational new therapeutic strategies can be developed to combat resistance. We used state-of-the-art computational approaches to systematically explore the mutational effects of ALK mutations on drug resistance properties. We found the activation of ALK was increased by substitution with destabilizing mutations, creating the capacity to confer drug resistance to inhibitors. In addition, results implied that evolutionary constraints might affect the drug resistance properties. Moreover, an extensive profile of drugs against ALK mutations was constructed to give better understanding of the mechanism of drug resistance based on structural transitions and energetic variation. Our work hopes to provide an up-to-date mechanistic framework for understanding the mechanisms of drug resistance induced by ALK mutations, thus tailor treatment decisions after the emergence of resistance in ALK-dependent diseases.
- Open Access
- 23 October 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (78) , 49244-49250
An in vitro test system for evaluation of SCAP–SREBP pathway inhibitory activities of Traditional Chinese Medicines
Cellular cholesterol levels are controlled by several transcription factors, including sterol-regulatory element-binding proteins (SREBPs). SREBP cleavage-activating protein (SCAP) acts as a cholesterol sensor responsible for regulating cellular cholesterol balance. We built an in vitro detection system to explore the SCAP–SREBP pathway inhibitory activities of Traditional Chinese Medicine (TCMs). Firstly, a bipartite graph composed of human disease and TCMs linked by medicine-disease binary associations was built. A subnetwork that contained about 100 kinds of medicines concerned with lipid metabolism was identified. Then a stable HepG2 cell line coupled to the firefly luciferase reporter gene was established to evaluate the SREBP pathway inhibitory activities of these medicines. Furthermore, the effects of synthesizing of endogenous cholesterol were investigated using reverse transcription polymerase chain reaction (RT-PCR) assay and amphotericin B cell model. Results revealed that crude extracts of Rhizoma Alismatis and Semen Cassiae showed favorable efforts on inhibiting the activities of SREBP pathway and the biosynthesis of cholesterol. Taken together, Rhizoma Alismatis and Semen Cassiae may be potential source of lipid-lowing drugs in the further drug discovery.
- 23 October 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (78) , 49244-49250
Open AccessAn in vitro test system for evaluation of SCAP–SREBP pathway inhibitory activities of Traditional Chinese Medicines
Cellular cholesterol levels are controlled by several transcription factors, including sterol-regulatory element-binding proteins (SREBPs). SREBP cleavage-activating protein (SCAP) acts as a cholesterol sensor responsible for regulating cellular cholesterol balance. We built an in vitro detection system to explore the SCAP–SREBP pathway inhibitory activities of Traditional Chinese Medicine (TCMs). Firstly, a bipartite graph composed of human disease and TCMs linked by medicine-disease binary associations was built. A subnetwork that contained about 100 kinds of medicines concerned with lipid metabolism was identified. Then a stable HepG2 cell line coupled to the firefly luciferase reporter gene was established to evaluate the SREBP pathway inhibitory activities of these medicines. Furthermore, the effects of synthesizing of endogenous cholesterol were investigated using reverse transcription polymerase chain reaction (RT-PCR) assay and amphotericin B cell model. Results revealed that crude extracts of Rhizoma Alismatis and Semen Cassiae showed favorable efforts on inhibiting the activities of SREBP pathway and the biosynthesis of cholesterol. Taken together, Rhizoma Alismatis and Semen Cassiae may be potential source of lipid-lowing drugs in the further drug discovery.